552c7ae14Space
The potential risk of NAION outweighs the health benefits of GLP-1 drugs
A JAMA Network Open study found a small but increased NAION risk in patients prescribed semaglutide or tirzepatide for type 2 diabetes.
552c7ae14Topic
552c7ae14Topic
GLP-1 drug side effects
Common and serious adverse reactions linked to GLP-1 drugs, including gastrointestinal symptoms, gallbladder issues, pancreatitis concerns, muscle loss, and long-term safety questions.
27 claims·2 news stories